City of Hope, formerly known as Cancer Treatment Centers of America (CTCA), is a US-based non-profit organization founded in 1988. It operates as a clinical cancer research center and hospital with approximately 2660 employees. The organization is headquartered in the United States and provides hospital and healthcare services.
City of Hope researchers presented data from a Phase 2 trial (NCT05672355) comparing a multi-antigen COVID-19 vaccine candidate, GEO-CM04S1, to an mRNA vaccine in patients with chronic lymphocytic leukemia (CLL). The trial showed GEO-CM04S1 outperformed the mRNA comparator. Separately, Dr. Percy Lee, medical director and vice chair for clinical research in the Department of Radiation Oncology, discussed expanding City of Hope's presence in Orange County and its radiation oncology research network. A City of Hope thoracic surgeon and health disparities researcher described ongoing work to address health inequities in lung cancer care. On September 11, 2024, the Newnan-Coweta Chamber of Commerce held a Business After Hours event at the City of Hope Cancer Center in Newnan.
Similar Companies
Subscribe for full access to City of Hope (CTCA)'s profile
City of Hope (CTCA) offers products in the media and telecoms services industry. City of Hope (CTCA)'s product portfolio comprises of media and TV services.
Subscribe for full access to City of Hope (CTCA)'s products in full detail
Subscribe for full access to City of Hope (CTCA)'s revenue in full detail
Subscribe for full access to City of Hope (CTCA)'s products in full detail 
